Blood Transfusion Devices Market

Name: Blood Transfusion Devices Market By Type (Apheresis Device, Blood Mixer, Blood Bag, Accessory, Filter, Pathogen Reduction System, Blood Component Separator, and Others), By End User (Hospitals, Blood Banks, Ambulatory Surgical Centres, and Others), Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026.
SKU: 2390

Blood Transfusion Devices Market By Type (Apheresis Device, Blood Mixer, Blood Bag, Accessory, Filter, Pathogen Reduction System, Blood Component Separator, and Others), By End User (Hospitals, Blood Banks, Ambulatory Surgical Centres, and Others), Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026.

Report ID

MSI-2390

Published

February 4, 2026

Pages

256 Pages

Format

Market Size 2026

Leadership Strategies

Key Trends

Market Size 2033

Report Details

Comprehensive Market Analysis And Insights

Market Definition

Blood transfusion devices are used for blood transfusion procedure. Blood transfusion involves the process of transferring blood or blood components to patients for replacing the lost components of the blood. Blood transfusion procedure is used for the treatment of various medical conditions such as cardiovascular procedures, C-section procedures, trauma and accident injuries. Blood transfusion devices include apheresis device, blood mixer, blood bag and accessory, filter, pathogen reduction system, blood component separator, and others.

Market Dynamics

Rising prevalence of blood-related disorders is driving the demand for blood transfusion devices market. For instance, according to the National Institutes of Health (NIH), in 2020, an estimate of 178,520 people in the US are expected to get diagnosed with leukemia, myeloma and lymphoma. According to the World Health Organization (WHO), around 5% of the world's population carries trait genes for hemoglobin disorders, such as sickle-cell disease and thalassaemia. Thalassemia affects 4.4 of every 10,000 live births throughout the world. According to the World Health Organization (WHO), globally, anaemia affects 1.62 billion people, which is 24.8% of the population. Further, the increasing number of surgical procedures is a key driving factor of the market. For instance, according to the National Center for Health Statistics, in the United States, more than 48 million surgical procedures were performed in 2018. According to the Centers for Disease Control and Prevention, in 2018, more than 1.2 million nervous system surgeries, 7.3 million Cardiovascular system surgeries, 5.2 million Musculoskeletal system surgeries, 6.1 million Digestive system surgeries, 1.3 million Respiratory system surgeries, 1.1 million Urinary system surgeries, and more than 3 million accounts for other surgeries than are performed in the United States. However, high costs of handling blood and its components might hamper the market growth. Moreover, technological advancements would provide lucrative opportunities for the market in coming years.

Market Segmentation

The global blood transfusion devices market is mainly classified based on type and end user. Type is further segmented into Apheresis Device, Blood Mixer, Blood Bag and Accessory, Filter, Pathogen Reduction System, Blood Component Separator, and Others. By end user, the market is divided into Hospitals, Blood Banks, Ambulatory Surgical Centres, and Others.

Apheresis systems hold a major share of the global transfusion devices market in 2019. Apheresis system is a device that receives blood from the donor’s body and separates it into various components such as platelets, red blood cells, plasma, and white blood cells. The commercialization of new apheresis system, the collaboration between companies to develop and distribute the apheresis system, and regulatory approval of the apheresis system are some of the factors driving the market demand. For instance, Terumo BCT has received CE mark approval for Spectra Optia Apheresis System with therapeutic plasma exchange (TPE) to treat Guillain-Barré syndrome (GBS) and myasthenia gravis (MG). The Spectra Optia system is a centrifugal therapeutic apheresis and cell collections platform. GBS and MG are rare and debilitating orphan neuromuscular diseases.

Regional Analysis

Based on geography, the global blood transfusion devices market is divided into North America, Europe, Asia-Pacific, South America, and Middle East & Africa. North America is further divided in the U.S., Canada, and Mexico, whereas Europe consists of the UK, Germany, France, Italy, and Rest of Europe. Asia-Pacific is segmented into India, China, Japan, South Korea, and Rest of Asia-Pacific. The South America region includes Brazil, Argentina, and the Rest of South America, while the Middle East & Africa is categorized into GCC Countries, Egypt, South Africa, and Rest of Middle East & Africa.

North America was dominating the blood transfusion devices market in 2019 and is expected to grow at a significant pace in future due to the rising prevalence of blood-related disorders and the increasing number of surgical procedures. Moreover, the commercialization of new blood transfusion devices is driving the demand for blood transfusion devices in the North American market. For instance, Ecomed Solutions has introduced its HEMAsavR device for blood capture and transfer to help allogenic blood transfusions. HEMAsavR is a sterile collection and transfer device that helps to collect more viable sterile and anti-coagulated blood to be evaluated for cell salvage processing.

Competitive landscape

Key players operating in the blood transfusion devices industry include B. Braun Melsungen AG, Becton Dickinson, Terumo Corporation, Fresenius Kabi AG, Grifols, S.A., Kawasumi Laboratories, Inc., Tenko Medical System Corp, Haemonetics Corporation, RAYS S.P.A., and Baxter International Inc.

The collaboration between companies to develop and supply blood transfusion devices, technological advancement, rising investment for the development for blood transfusion system, regulatory approval of blood transfusion devices and commercialization of new blood transfusion system are some of the strategies adopted by the major players. For instance, on June 10, 2020, ProCell Surgical Inc. has introduced ProCell, a medical device designed to effectively automate the manual and outdated activity of surgical sponge-blood recovery for intraoperative autotransfusion (IAT). ProCell is the more efficient blood collection process.

Blood Transfusion Devices Market Key Segments:

By Type